ASP

Nicholas Clark appointed as Coastal Carolina Athletics’ first in-house NIL general manager

Retrieved on: 
金曜日, 5月 24, 2024
Coastal Carolina University, Partnership, Legislation, Athlete, Sun Belt Conference, Education, Alumni, University, Conference, ASP, NIL, Growth, NCAA, CCU, Georgia State University, Chanticleer, GM, Communication, Tennessee State University, Family, Management

Conway, S.C., May 24, 2024 (GLOBE NEWSWIRE) -- Coastal Carolina University (CCU), in partnership with Altius Sports Partners (ASP), announces the appointment of Nicholas Clark as the first in-house Name, Image, and Likeness (NIL) general manager.

Key Points: 
  • Conway, S.C., May 24, 2024 (GLOBE NEWSWIRE) -- Coastal Carolina University (CCU), in partnership with Altius Sports Partners (ASP), announces the appointment of Nicholas Clark as the first in-house Name, Image, and Likeness (NIL) general manager.
  • Coastal Carolina is the first Sun Belt Conference school in ASP’s General Manager program.
  • Coming back as the ASP NIL general manager, I’m committed to leveraging my experiences and the insights I’ve gained to significantly enhance our student-athletes’ experiences.
  • Following his undergraduate studies, Clark earned advanced degrees from Georgia State University, the University of Virginia, and Tennessee State University.

Skyline Champion Announces Fourth Quarter and Full Year Fiscal 2024 Results; Announces New $100 Million Share Repurchase Program

Retrieved on: 
火曜日, 5月 21, 2024
Interior Design, Architecture, Residential Building & Real Estate, Construction & Property, Urban Planning, Building Systems, Share repurchase, FEMA, ASPS, Conference call, Investment, Conference, ASP, Acquisition, GAAP, SKY, Environment, Water, Plant, Video game

Skyline Champion Corporation (NYSE: SKY) (“Skyline Champion”) today announced financial results for its fourth quarter and full year ended March 30, 2024 (“fiscal 2024”).

Key Points: 
  • Skyline Champion Corporation (NYSE: SKY) (“Skyline Champion”) today announced financial results for its fourth quarter and full year ended March 30, 2024 (“fiscal 2024”).
  • Gross profit decreased by 30.3% to $98.4 million in the fourth quarter fiscal 2024 compared to the prior-year period.
  • Selling, general, and administrative expenses (“SG&A”) in the fourth quarter fiscal 2024 increased to $90.6 million from $72.4 million in the same period last year.
  • Adjusted EBITDA for the fourth quarter fiscal 2024 decreased by 30.2% to $53.1 million compared to the fourth quarter fiscal 2023.

James Hardie Industries Announces Fourth Quarter And Fiscal Year 2024 Results

Retrieved on: 
月曜日, 5月 20, 2024
Professional Services, Insurance, Finance, ASX, HMOS, James Hardie Industries, HOS, Calendar, Marketing, Housing, ASP, Customer, EPS, Growth, High value products, JHX, Public expenditure

James Hardie Industries plc (ASX: JHX; NYSE: JHX), today announced results for its fourth quarter ending 31 March 2024.

Key Points: 
  • James Hardie Industries plc (ASX: JHX; NYSE: JHX), today announced results for its fourth quarter ending 31 March 2024.
  • This focus has enabled us to deliver a strong fourth quarter and fiscal year for Adjusted Net Income.”
    Mr. Erter continued, “I believe our fiscal year results are proof points that we are accelerating through this cycle and taking share.
  • Sequentially, SG&A was up 2% versus the third quarter of fiscal year 2024.
  • Sequentially, SG&A was up 12% versus the third quarter of fiscal year 2024.

DermTech Reports First-Quarter 2024 Financial Results

Retrieved on: 
火曜日, 5月 14, 2024
Biotechnology, General Health, Health, Genetics, Health Technology, ASP, Research, DMT, Trial of the century, Marketing, Dermatology, Pharmaceutical industry

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its first-quarter 2024 financial results.

Key Points: 
  • DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its first-quarter 2024 financial results.
  • Test revenue was $3.7 million, up 7 percent from the first quarter of 2023, primarily due to a higher ASP for the DMT.
  • Total revenue was $3.8 million, an 11 percent increase from the first quarter of 2023, driven by higher test revenue.
  • Cash, cash equivalents, restricted cash and short-term marketable securities were $42.4 million as of March 31, 2024.

Sage Transparency™ Relaunches With New Features and New RAND Hospital Price Data

Retrieved on: 
月曜日, 5月 13, 2024
Indiana House of Representatives, Hospital, Medicare, System, Conference, ASP, Representative, National academy, Data science, Consultant, Policy, Patient safety, Employment, Health policy, National Healthcare, Mortality, Abdominal ultrasonography, Health insurance

INDIANAPOLIS, May 13, 2024 /PRNewswire/ -- Employers' Forum of Indiana introduced Sage Transparency™ 2.0, a major update to the free, publicly accessible hospital price and quality dashboard, today at the National Healthcare Price Transparency Conference in Indianapolis. Sage Transparency, which was first made available in 2022, is a browser-based dashboard that helps inform employers, policymakers, and more on the real prices that employers pay for hospital services across the country. The 2.0 update integrates new data from the Employer Price Transparency study, which RAND published earlier today. Users can now see prices from 2020 to 2022 for more than 4,000 hospitals and 2,000 ambulatory surgery centers (ASCs) nationwide along with brand-new drug price data for physician-administered medications. Additional features such as the ability to purchase  custom reports from within the platform are on the horizon.

Key Points: 
  • Round five of the Employer Hospital Price Transparency study, conducted by RAND, creates the foundation for Sage Transparency™ 2.0, the free, public dashboard on nationwide hospital price and quality data
    INDIANAPOLIS, May 13, 2024 /PRNewswire/ -- Employers' Forum of Indiana introduced Sage Transparency™ 2.0 , a major update to the free, publicly accessible hospital price and quality dashboard, today at the National Healthcare Price Transparency Conference in Indianapolis.
  • The 2.0 update integrates new data from the Employer Price Transparency study , which RAND published earlier today.
  • Additional features such as the ability to purchase  custom reports from within the platform are on the horizon.
  • Sage Transparency 2.0 integrates data from the Employer Price Transparency study, Centers for Medicare & Medicaid Services , Healthcare Bluebook , the National Academy for State Health Policy , and January Advisors .

Canadian Solar Reports First Quarter 2024 Results and Announces Appointment of Chief Financial Officer

Retrieved on: 
木曜日, 5月 9, 2024
CFO, Topcon, Total, Nominal power (photovoltaic), Recurrence, Depreciation, PERC, Professional, Kilowatt-hour, Engineering, Senior, Acquisition, ASPS, FIT, PPA, BlackRock, GWP, ASP, EPC, Growth, Renewable energy

GUELPH, ON, May 9, 2024 /PRNewswire/ -- Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced financial results for the first quarter ended March 31, 2024.

Key Points: 
  • GUELPH, ON, May 9, 2024 /PRNewswire/ -- Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced financial results for the first quarter ended March 31, 2024.
  • Appointment of Mr. Xinbo Zhu as Senior Vice President and Chief Financial Officer, effective May 15, 2024.
  • Dr. Huifeng Chang, who has served as Chief Financial Officer since May 2016, will transition into his new role within the Company as Chief Strategy Officer.
  • Yan Zhuang, President of Canadian Solar's CSI Solar subsidiary, said, "Despite the seasonally softer first quarter, we delivered strong results.

Brilliant Earth Reports First Quarter 2024 Results

Retrieved on: 
木曜日, 5月 9, 2024
Entrepreneurship, Growth, Earth Group, Adjustment, ASP, SAN, Brilliant Earth

SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced financial results for the three months ended March 31, 2024.

Key Points: 
  • SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced financial results for the three months ended March 31, 2024.
  • This was another quarter that resulted in strong total and repeat order growth, ASP increases, and strong fine jewelry performance,” said Beth Gerstein, Co-Founder and Chief Executive Officer of Brilliant Earth.
  • “We are also pleased to report our eleventh straight quarter of positive adjusted EBITDA as a public company.
  • We continue to drive a consistent record of gaining market share and delivering profitability through many environments with our dynamic, data-driven business model.”
    “We are beginning the year with positive momentum, and we believe we are in a great position to deliver on our strategic and financial goals for the full fiscal year,” said Gerstein.

Arq Reports First Quarter 2024 Results

Retrieved on: 
水曜日, 5月 8, 2024
Carbon, GAC, Sale, PFAS, EPA, Drinking water, Investment, Capital, Red, Research, Depreciation, Yoy, Hand, Capital expenditure, Public expenditure, Net operating loss, Steel, Acquisition, Operating cost, Adjustment, ASP, GAAP, Growth, Interest

GREENWOOD VILLAGE, Colo., May 08, 2024 (GLOBE NEWSWIRE) -- Arq, Inc. (NASDAQ: ARQ) (the "Company" or "Arq"), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced its financial and operating results for the quarter ended March 31, 2024.

Key Points: 
  • Red River expansion remains on schedule for first production in Q4 2024; expected payback of 3 years or less
    GREENWOOD VILLAGE, Colo., May 08, 2024 (GLOBE NEWSWIRE) -- Arq, Inc. (NASDAQ: ARQ) (the "Company" or "Arq"), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced its financial and operating results for the quarter ended March 31, 2024.
  • Average selling price for the first quarter of 2024 was up approximately 16% compared to prior year period, marking the fourth consecutive quarter of double-digit year-over-year percentage growth in ASP.
  • Gross margin improved to 37% for the first quarter of 2024, compared to 17% in the prior year period.
  • Income tax expenses were zero in the first quarter of 2024, compared to negligible amounts in the prior year period.

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

Retrieved on: 
月曜日, 5月 6, 2024
International, Person, Investment, Publication, Depreciation, DSM-IV codes, Surgeon, Security (finance), Research, Webcast, Anatomy, Risk, Patient, Worldwide, All rights reserved, Physician, Form 10-K, Bank statement, Deformity, ASP, GAAP, Growth, Bookkeeping

Gross margin was ~79% for the first quarter 2024, as compared to ~82% in the corresponding period in 2023.

Key Points: 
  • Gross margin was ~79% for the first quarter 2024, as compared to ~82% in the corresponding period in 2023.
  • Gross margin in the first quarter 2024 was impacted by procedure and product mix.
  • Operating expenses increased ~10% to $41.9 million in the first quarter 2024, as compared to $38.1 million in the corresponding period in 2023.
  • SI-BONE will host a conference call to discuss the first quarter 2024 financial results after market close on Monday, November 6, 2023 at 4:30 P.M. Eastern Time.

Myomo Reports First Quarter 2024 Financial Results

Retrieved on: 
水曜日, 5月 8, 2024
Robotics, Medical Devices, Health, Technology, Neurology, Biotechnology, Medicare (United States), Table, CMS, International, Investment, PIN, Growth, Webcast, Patient, Operating cost, Medicare, DME, ASP, GAAP

Myomo recognized revenue on 91 MyoPro units in the first quarter of 2024, up 14% compared with the same quarter a year ago.

Key Points: 
  • Myomo recognized revenue on 91 MyoPro units in the first quarter of 2024, up 14% compared with the same quarter a year ago.
  • Gross margin for the first quarter of 2024 was 61.2%, compared with 67.0% for the first quarter of 2023.
  • Operating expenses for the first quarter of 2024 were $6.2 million, an increase of 24% compared with the first quarter of 2023.
  • Adjusted EBITDA for the first quarter of 2024 was $(3.5) million, compared with $(2.5) million for the first quarter of 2023.